Monday, 21 May 2018 - 21:46
  • it
  • de
  • en
  • fr


Dompé’s cenegermin eye drops approved in Europe

The European Commission adopted a positive opinion on the commercialization of Dompé’s cenegermin eye drops for the treatment of moderate or severe neurotrophic keratitis in adults. Dompé also submitted a Biologics License Application for the treatment to FDA. The Company…

Bracco to sell Pharma Division to Dompé

Bracco and Dompé have signed an agreement under which Bracco will sell its Pharma Division to Dompé. Such Division is expected to produce a sales volume of approximately €80m in 2016—equal to 6% of the Group’s total sales—and operates only…